Skip to content

Effect of salbutamol and magnesium sulfate nebulizer compared with salbutamol and normal saline nebulizer in the treatment of acute asthma attack

Effect of salbutamol and magnesium sulfate nebulizer compared with salbutamol and normal saline nebulizer in the treatment of acute asthma attack

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT201110024396N3
Enrollment
40
Registered
2012-04-16
Start date
2011-03-21
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pediatric asthma. Asthma, unspecified

Interventions

Intervention 1: At first the asthma is diagnosed according to GINA criteria and history, clinical examination and if possible, respiratory function tests and will be categorized as moderate to severe
Treatment - Drugs
At first the asthma is diagnosed according to GINA criteria and history, clinical examination and if possible, respiratory function tests and will be categorized as moderate to severe asthma. before

Sponsors

Vice chancellor for research, Babol University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
5 Years to 14 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Children aged 5-14 years, suffering from moderate or severe asthma with asthma attack Exclusion criteria: History of steroid therapy, theophylline, Atrovent in the past three days; a history of chronic diseases such as Bronchopulmonary dysplasia, cystic fibrosis and known allergy to magnesium sulphate and salbutamol and the inability to perform peak flow meter

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Increase of PEFR (Peak Expiratory Flow Rate). Timepoint: 0,30,60 and 90 minutes after entrance. Method of measurement: With peak flow meter.

Secondary

MeasureTime frame
Pulmonary index. Timepoint: At 0, 30, 60 , 90th minute. Method of measurement: By using Pulmonary index table.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactIraj Mohammadzadeh, MD

Non-Communicable Pediatric Diseases Research Center

i.mohammadzadeh@mubabol.ac.ir+98 911 111 2228

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026